Related Experiment Videos
Clinical and experimental features of MuSK antibody positive MG in Japan
K Ohta1, K Shigemoto, A Fujinami
1Clinical Research Center, Utano National Hospital, Kyoto, Japan. mohta@kobepharma-u.ac.jp
Abstract:
We investigated the presence of antibodies (Abs) against muscle-specific tyrosine kinase (MuSK) in Japanese myasthenia gravis (MG) patients. MuSK Abs were found in 23 (27%) of 85 generalized seronegative MG (SNMG) patients but not in any of the ocular MG patients. MuSK Ab-positive patients were characterized as having female dominance (M:F, 5:18), age range at onset 18 to 72 (median 45) years old, and prominent oculobulbar symptoms (100%) with neck (57%) or respiratory (35%) muscle weakness. Limb muscle weakness was comparatively less severe (52%), thymoma absent. Most patients had good responses to simple plasma exchange and steroid therapy. MuSK IgG from all 18 patients was exclusively the IgG 4 subclass and bound mainly with the MuSK Ig 1-2 domain. Serial studies of 12 individuals showed a close correlation between the variation in MuSK Ab titers and MG clinical severity (P = 0.01 by Kruskal-Wallis). MuSK Ab titers were sharply decreased in patients who had a good response to early steroid therapy or simple plasma exchange, but there was no change, or a rapid increase on exacerbation after thymectomy. Measurement of MuSK Ab titers aids in the diagnosis of MG and the monitoring of clinical courses after treatment.
Insights
Antibodies against muscle-specific tyrosine kinase (MuSK) were identified in Japanese myasthenia gravis (MG) patients. Measuring MuSK antibody levels helps diagnose MG and monitor treatment effectiveness.
Area of Science:
- Neurology
- Immunology
Background:
- Myasthenia gravis (MG) is a neuromuscular autoimmune disease.
- Seronegative MG (SNMG) presents diagnostic challenges.
- Muscle-specific tyrosine kinase (MuSK) is an important target in some MG cases.
Purpose of the Study:
- To investigate the prevalence and characteristics of MuSK antibodies in Japanese MG patients.
- To evaluate the clinical significance of MuSK antibodies in MG diagnosis and management.
Main Methods:
- Serological testing for MuSK antibodies in generalized SNMG and ocular MG patients.
- Clinical data collection including demographics, symptoms, and treatment response.
- Analysis of antibody subclass and binding domain.
- Correlation analysis between antibody titers and clinical severity.
Main Results:
- MuSK antibodies were detected in 27% of generalized SNMG patients, predominantly females, with prominent oculobulbar and neck/respiratory weakness.
- MuSK antibody-positive patients showed good response to plasma exchange and steroids; IgG4 was the exclusive subclass.
- MuSK antibody titers correlated with MG clinical severity and decreased with effective treatment, but increased post-thymectomy.
- Thymoma was absent in MuSK antibody-positive patients.
Conclusions:
- MuSK antibodies are a significant diagnostic marker in a subset of Japanese SNMG patients.
- Monitoring MuSK antibody titers can aid in diagnosing MG and tracking disease activity and treatment response.
- The findings highlight the role of MuSK antibodies in specific MG phenotypes and inform therapeutic strategies.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...